|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
University Medicine, Southampton General Hospital, Southampton, United Kingdom
Cysteinyl-leukotrienes are potent bronchoconstrictor mediators synthesized by the 5-lipoxygenase (5-LO) pathway. Eosinophilopoietic cytokines such as IL-5 enhance cysteinyl-leukotriene synthesis in eosinophils in vitro, mimicking changes in eosinophils from asthmatic patients, but the mechanism is unknown. We hypothesized that IL-5 induces the expression of 5-LO and/or its activating protein FLAP in eosinophils, and that this might be modulated by anti-inflammatory corticosteroids. Compared with control cultures, IL-5 increased the proportion of normal blood eosinophils immunostaining for FLAP (65 ± 4 vs 34 ± 4%; p < 0.0001), enhanced immunoblot levels of FLAP by 51 ± 14% (p = 0.03), and quadrupled ionophore-stimulated leukotriene C4 synthesis from 5.7 to 20.8 ng/106 cells (p < 0.02). IL-5 effects persisted for 24 h and were abolished by cycloheximide and actinomycin D. The proportion of FLAP+ eosinophils was also increased by dexamethasone (p < 0.0001). Neither IL-5 nor dexamethasone altered 5-LO expression, but IL-5 significantly increased 5-LO immunofluorescence localizing to eosinophil nuclei. Compared with normal subjects, allergic asthmatic patients had a greater proportion of circulating FLAP+ eosinophils (46 ± 6 vs 27 ± 3%; p < 0.03) and a smaller IL-5-induced increase in FLAP immunoreactivity (p < 0.05). Thus, IL-5 increases FLAP expression and translocates 5-LO to the nucleus in normal blood eosinophils in vitro. This is associated with an enhanced capacity for cysteinyl-leukotriene synthesis and mimics in vivo increases in FLAP expression in eosinophils from allergic asthmatics.
This article has been cited by other articles:
![]() |
M. Peters-Golden and W. R. Henderson Jr. Leukotrienes N. Engl. J. Med., November 1, 2007; 357(18): 1841 - 1854. [Full Text] [PDF] |
||||
![]() |
M. Luo, S. M. Jones, N. Flamand, D. M. Aronoff, M. Peters-Golden, and T. G. Brock Phosphorylation by Protein Kinase A Inhibits Nuclear Import of 5-Lipoxygenase J. Biol. Chem., December 9, 2005; 280(49): 40609 - 40616. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Luo, S. M. Jones, M. Peters-Golden, and T. G. Brock Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity PNAS, October 14, 2003; 100(21): 12165 - 12170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Jones, M. Luo, M. Peters-Golden, and T. G. Brock Identification of Two Novel Nuclear Import Sequences on the 5-Lipoxygenase Protein J. Biol. Chem., March 14, 2003; 278(12): 10257 - 10263. [Abstract] [Full Text] [PDF] |
||||
![]() |
Spoken sessions Thorax, December 1, 2002; 57(90003): iii3 - 47. [Full Text] [PDF] |
||||
![]() |
M. L. SEYMOUR, S. RAK, D. ABERG, G. C. RIISE, J. F. PENROSE, Y. KANAOKA, K. F. AUSTEN, S. T. HOLGATE, and A. P. SAMPSON Leukotriene and Prostanoid Pathway Enzymes in Bronchial Biopsies of Seasonal Allergic Asthmatics Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2051 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Coffey, S. M. Phare, and M. Peters-Golden Peroxynitrite-Induced Nitrotyrosination of Proteins Is Blocked by Direct 5-Lipoxygenase Inhibitor Zileuton J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 198 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Salvi, M. T. Krishna, A. P. Sampson, and S. T. Holgate The Anti-inflammatory Effects of Leukotriene-Modifying Drugs and Their Use in Asthma Chest, May 1, 2001; 119(5): 1533 - 1546. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. H. Hsieh, B. K. Lam, J. F. Penrose, K. F. Austen, and J. A. Boyce T Helper Cell Type 2 Cytokines Coordinately Regulate Immunoglobulin E-dependent Cysteinyl Leukotriene Production by Human Cord Blood-derived Mast Cells: Profound Induction of Leukotriene C4 Synthase Expression by Interleukin 4 J. Exp. Med., January 2, 2001; 193(1): 123 - 134. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Urasaki, J. Takasaki, T. Nagasawa, and H. Ninomiya Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway J. Leukoc. Biol., January 1, 2001; 69(1): 105 - 112. [Abstract] [Full Text] |
||||
![]() |
S.-J. Chu, L.-O. Tang, E. Watney, E. Y. Chi, and W. R. Henderson Jr. In Situ Amplification of 5-Lipoxygenase and 5-Lipoxygenase-Activating Protein in Allergic Airway Inflammation and Inhibition by Leukotriene Blockade J. Immunol., October 15, 2000; 165(8): 4640 - 4648. [Abstract] [Full Text] [PDF] |
||||
![]() |
A P Sampson, S Siddiqui, D Buchanan, P H Howarth, S T Holgate, J W Holloway, and I Sayers Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast Thorax, October 1, 2000; 55(90002): 28S - 31. [Full Text] |
||||
![]() |
M. Sanak, M. Pierzchalska, S. Bazan-Socha, and A. Szczeklik Enhanced Expression of the Leukotriene C4 Synthase Due to Overactive Transcription of an Allelic Variant Associated with Aspirin-Intolerant Asthma Am. J. Respir. Cell Mol. Biol., September 1, 2000; 23(3): 290 - 296. [Abstract] [Full Text] |
||||
![]() |
R. STOKES PEEBLES Jr., R. DWORSKI, R. D. COLLINS, K. JARZECKA, D. B. MITCHELL, B. S. GRAHAM, and J. R. SHELLER Cyclooxygenase Inhibition Increases Interleukin 5 and Interleukin 13 Production and Airway Hyperresponsiveness in Allergic Mice Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 676 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Campbell Smoking cessation Thorax, August 1, 2000; 55(90001): S28 - 31. [PDF] |
||||
![]() |
N. M. Munoz, G. A. van Seventer, R. T. Semnani, and A. R. Leff Augmentation of LTC4 synthesis in human eosinophils caused by CD3-stimulated Th2-like cells in vitro Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1172 - L1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hojo, M. Suzuki, K. Maghni, Q. Hamid, W. S. Powell, and J. G. Martin Role of Cysteinyl Leukotrienes in CD4+ T Cell-Driven Late Allergic Airway Responses J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 410 - 416. [Abstract] [Full Text] |
||||
![]() |
P. P Hood, T. P Cotter, J. F Costello, and A. P Sampson Effect of intravenous corticosteroid on ex vivo leukotriene generation by blood leucocytes of normal and asthmatic patients Thorax, December 1, 1999; 54(12): 1075 - 1082. [Abstract] [Full Text] |
||||
![]() |
C. Bandeira-Melo, M. Phoofolo, and P. F. Weller Extranuclear Lipid Bodies, Elicited by CCR3-mediated Signaling Pathways, Are the Sites of Chemokine-enhanced Leukotriene C4 Production in Eosinophils and Basophils J. Biol. Chem., June 15, 2001; 276(25): 22779 - 22787. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. G. Brock, E. Maydanski, R. W. McNish, and M. Peters-Golden Co-localization of Leukotriene A4 Hydrolase with 5-Lipoxygenase in Nuclei of Alveolar Macrophages and Rat Basophilic Leukemia Cells but Not Neutrophils J. Biol. Chem., September 7, 2001; 276(37): 35071 - 35077. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |